Winning
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Google abandoned their plans for a smart contact lens because their technology was highly insufficient and simply never worked and will work. Their attempted partnership with EPGL went up in smoke because they were too stupid and Coopervision snagged them first, which resulted in EPGL retaining all rights to the tech after COO got greedy. Google then failed to come up with anything partnering with a company that is no wear close to being in the race. fact is, Google realizes that their money is better spent on other projects that they can succeed with. They will simply buy a company in the future that has been able to do what they couldn't and save themselves a ton of money and time in the process.
Buyout is the play. All depends what comes first. IPO then buyout, or buyout before the IPO. All questions of ‘if’ are gone, for me, given what I have seen and heard. Just a matter of ‘when’
I was fortunate enough to meet with and talk to WSGR reps while being present for the vote. What they think of EPGL's (InWith) IP and where its heading, has them very excited. While it will take a long time and cost a lot of money to get the tech to market, they are confident, given their countless connections with heavy weights and knowledge of the IP, that everything will come to fruition. And remember, they take on shares of nearly every start-up they rep.
The current partnership EPGL (InWith) has with a massive blue chip to develop a working prototype within 2018, only solidifies their IP and capabilities. WSGR is now clearing the path for EPGL (InWith) to continue its progression.
A buyout will occur before a new IPO is launched.
Knowledge is power.
While I love good news, and this is good news, nobody has heard of DiMora, so I wouldn't expect any excitement over it until future financials prove it to be a profitable venture. That being said, its is another achievement Moovly has made and awareness will continue.
Remains a strong buyout candidate from giants such as Google, Adobe, etc.
A reminder of Google's failed plan for smart contact lenses. They will now simply buyout the company that brings it to market first, with all likelihood, that company being EPGL. The only other players are sensimed and samsung and they are years behind EPGL Med.
Google Out of the Race
I'd say 90% of the trade blocks going through are small blocks. Trades made by investors with minimal amounts. There is no reason for them to hold through conversion. Being the long term nature of the play to meet it's goals, theres no point in in holding a few 100 shares of InWith. My advice to these investors, is to sell these shares immediately to those accumulating, at the lowest price possible, the price at which the majority of accumulators will accept! Good luck!
The recent capital raise is going as expected, since they increased the size to meet demand. Versus Systems is starting it's new phase in this journey.
Once Versus goes live, new partners and money will flood to the company. The technology works. Will be huge among gamers everywhere, and in games of all shapes and sizes.
Beat is about to end and Versus will be fully live. Play a game. Make money and earn prizes.
Dr. David Markus is the one of the leading researchers/scientists when it comes to smart contact lenses. And an invented named on multiple smart contact lens patents and patents pending.
Currently serving as EPGL's head of development and will soon be president of EPGL's new private company that will create the worlds first, marketable smart contact lens.
Markus has ah an extensive background in MEMS, microelectronics, and biomedical engineering. He was also a principal investigator at DARPA, where the forefront of MEMS research has been conducted for years. “They brought together the best scientists in America, essentially doing research that is so advanced, it has little practical use, but not in all cases” Markus laughs. “As a result of being part of those programs and others, some new advanced technology was developed and I just so happened to be involved in the development of some of those technologies. As a result I was able to know how to replicate them for practical use in the medical field.”
Just another example what smart lens technology will be doing. And another example of another company that will have to license EPGL technology to manufacture the lens. The elastic circuit patent is king.
eyewiretoday.com/2018/03/22/iot-launches-inmotion-daily-driving-lens
$InWith Corp. signed with a new stock transfer company this week (the best) and this is adding some needed days to the process of share distribution /conversion, which has started. $EPGL will trade for a few more days as this process is being completed.
The company InWith continues it's pursuit of BioMem technology along with many others seeking to take part in the rapidly growing sector that will be putting technology into our bodies! Times are a changing.
Versus Announces Upsize of Previously Announced Private Placement to $4 Million
https://webfiles.thecse.com/investorx/VS/1803211511507142.pdf?bfsB805xbIdpA5Cg5qvEDPCQH65qHBxB" rel="nofollow" target="_blank" >https://webfiles.thecse.com/investorx/VS/1803211511507142.pdf?bfsB805xbIdpA5Cg5qvEDPCQH65qHBxB
VANCOUVER, British Columbia, March 21, 2018 -- Versus Systems Inc. (“Versus” or the “Company”) (CSE:VS)
(CSE:VS.CN) (OTCQB:VRSSF) (FRANKFURT:BMVA) announces that is has amended its letter of engagement with Eight
Capital, as lead agent (the “Lead Agent”), on behalf of a syndicate of agents including Canaccord Genuity Corp., Gravitas
Securities Inc., and Leede Jones Gable Inc. (together with the Lead Agent, the “Agents”), to increase the size of the
previously announced $3,000,000 offering of units of the Company (“Units”) on a “best efforts” private placement basis (the
“Offering”) to $4,000,000.
The purchase price for each Unit shall remain $0.30 (the “Issue Price”). Each Unit shall consist of one common share of the
Company (a “Share”) and one-half of one common share purchase warrant (each full warrant, a “Warrant”). Each Warrant
shall entitle the holder thereof to acquire one Share at a price of $0.40 per Share for a period of 24 months following the closing
date of the Offering.
Having their new script pricing process in effect since 4thQ, 1st Q numbers will be key to see how demand is increasing or decreasing.
Moovly's deal with shutter stock is creating competition against Adobe, taking away market share from After Effects.
Moovly moving front and center on the buyout radar.
Great summit in Vegas this week. Adobe's platform is much like Moovly's
Yup. They take on equity many of the companies they represent. Acting as a major liaison between all of the tech heavy giants, VC's, etc, for startups that are their clients, they move companies forward. Simple as that. The partner I talked to is fired up about all of EPGL's IP, saying that the Elastic Circuit patent is a major approval. Never seen a bigger no brainer then to own as much InWith as humanly possible. Once everything is finalized and InWith/EPGL, progress will jump. Hopefully the majority of current shareholders bail.
Nice. Somebody's loss will be your profitable gain. Hopefully we shed more dead weight.
Looks like we could see a move this coming week? Thoughts?
"In January 2016, as part of the 2016 Omnibus Appropriations Act (the Act) passed by the United States Congress, an amendment was added that directed the FDA to issue final guidance for the labelling of AquAdvantage Salmon. Given this directive, the FDA issued an Import Alert on the fish and stated that a temporary hold was being implemented to comply with language in the Act, which was extended beyond its initial end date several times to March 23, 2018, by continuing resolutions. At this time, the Company cannot predict when or if the Import Alert might be lifted or when the FDA might finalize its labelling guidance."
Gonna be good. Smart investors will soon be invested in a private company that is sitting on ground breaking technology, that with time, will dominate the smart lens market. With WSGR investing in InWith and acting as a liaison between billion dollar companies and VC's, for InWith, as they were for Google in the beginning, the opportunities are endless. The guy that worked the Google deal is very excited for what inWith brings to the table. Its going to take a while, but an IPO or buyout is essentially a guarantee.
With any luck they will! Glad I got to talk to tech experts at WSGR, whom are invested and represent InWith, and where they think InWith's IP will take them. The quality of the IP is superior to whats out there, from what they have seen. It will take a while to bring it to market, but all the necessary components are there for success. This has been the easiest investment I have ever made. Knowledge is power. Still hoping for the meek and weary to abandon ship. Hopefully only two more trading days remain.
Just MM's straightening out their books at the end of the day. That lil t-trade will probably the most volume we see until the last day of trading. Progress continues
The horror! The HORROR! C’mon people take your losses! Exit! We want .005’s!
Very awesome! A good reminder of how everything is progressing.
So many accomplishments. Expect specific prototype completion in 2nd half 2018 for a multi billion dollar company. So much news coming in the 2nd half. Glad to have WSGR as investors and representation. They will be at the forefront of creating additional relationships with VC’s and corporate partnerships. Gonna be good.
Progress continues.
Always a joy knowing the truth and being steps ahead of those who refuse to acknowledge the truth. Progress continues!
Quite the accusation. Good thing I got to meet them both. Knowledge is power. Good luck!
Definitely not many. I can't wait for the final ten minutes of the last day of trading. Maybe then we'll see a potential flood.
With only 377K volume? Thought more failed traders would be capitulating by now. Hopefully selling volume picks up and I'm rewarded. Max pain enthusiasts are coming!
Always remember there will max pain sellers. OTC investors tend to be gluttons for feeling max pain. They will come. Of course there’s a chance they won’t. Are buyers like myself willing to risk missing out on .009’s for the chance of, say .005’s? Yup!
Best move Hayes has made. WSGR has big ideas for InWith once they are private. It’s going to be good. Knowledge is power. To each their own. Good luck!
As far as what will happen to the EPGL board going forward, it will remain up after the company is taken over by InWith, with the acronym FKA added to the ticker, meaning, 'formerly known as'.
Hope this helps those whom are curious.
So fun today, listening to people's theories on EPGL. Both good and bad. Good luck to the massive amount of investors converting and going with the new company. Seems like if investors thought their shares were in fact going to be worthless down the road, with the new company, that they'd sell and salvage what little they could at current levels. Looks like everybody believes that their shares will be worth over the current ops when all is said and done.
Knowledge is power and I am blessed to have it.
"Who in their right mind would trade real money for these voodoo magic, “private” shares"
Those whom have met all the players involved and have heard what professionals have had to say as opposed to believing in conspiracy theories. Knowledge is power.
Hopefully there will be refusals. Max pain losers will give me the shares I want.